206 related articles for article (PubMed ID: 21459633)
1. The immunohistochemical profile of oral inflammatory myofibroblastic tumors.
Salgueiredo-Giudice F; Fornias-Sperandio F; Martins-Pereira E; da Costa dal Vechio AM; de Sousa SC; dos Santos-Pinto-Junior D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jun; 111(6):749-56. PubMed ID: 21459633
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
3. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
Zhang YH; Zhang XR; Yu J; Li HL
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
[No Abstract] [Full Text] [Related]
6. Clinicopathological and immunohistochemical features of oral spindle cell carcinoma.
Romañach MJ; Azevedo RS; Carlos R; de Almeida OP; Pires FR
J Oral Pathol Med; 2010 Apr; 39(4):335-41. PubMed ID: 20002980
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study of sinonasal inflammatory myofibroblastic tumor].
He CY; Jin YL; Yang DM; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):166-71. PubMed ID: 20450762
[TBL] [Abstract][Full Text] [Related]
8. Low-grade myofibroblastic sarcoma of the maxillary region in a dog.
Tsuchiya T; Suzuki K; Hojo Y; Shiraki A; Imaoka M; Shibutani M; Mitsumori K
J Comp Pathol; 2012 Jul; 147(1):42-5. PubMed ID: 21996034
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
Shintaku M; Fukushima A
Pathol Int; 2006 Oct; 56(10):625-8. PubMed ID: 16984620
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory myofibroblastic tumor of bladder: a clinicopathologic study of five cases].
Sun K; Wang ZM; Xu LJ; Teng XD; Yao HT; Ren GP
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):605-8. PubMed ID: 18070449
[TBL] [Abstract][Full Text] [Related]
11. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory myofibroblastic tumor of the alveolar mucosa of the mandible.
Johann AC; Caldeira PC; Abdo EN; Sousa SO; Aguiar MC; Mesquita RA
Minerva Stomatol; 2008; 57(1-2):59-63. PubMed ID: 18427372
[TBL] [Abstract][Full Text] [Related]
13. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin as an adjuvant in the diagnosis of oral inflammatory myofibroblastic tumor.
Xavier FC; Rocha AC; Sugaya NN; dos Santos-Pinto D; de Sousa SC
Med Oral Patol Oral Cir Bucal; 2009 Dec; 14(12):e635-9. PubMed ID: 19680189
[TBL] [Abstract][Full Text] [Related]
16. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma.
Etemad-Moghadam S; Khalili M; Tirgary F; Alaeddini M
J Oral Pathol Med; 2009 Sep; 38(8):639-43. PubMed ID: 19473444
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone.
Romeo S; Eyden B; Prins FA; Briaire-de Bruijn IH; Taminiau AH; Hogendoorn PC
J Pathol; 2006 Jan; 208(1):26-34. PubMed ID: 16278817
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features of inflammatory myofibroblastic tumors of the lung].
Yang H; Xie R; Xiao J; Zhang S
Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):116-9. PubMed ID: 21114933
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
